$AITX CEO Steve Reinharz Publishes Article Making the Case

FDA's Seal of Approval: A Game Changer Well, folks, here's a twist in the story of cancer treatment with FDA giving a nod to RYBREVANT FASPRO. Johnson & Johnson's latest offering, fueled by Halozyme's groundbreaking ENHANZE technology, just snagged accelerated approval. We're not just talking any old treatment here; it's a dual-targeted therapy for head and neck cancer...

Investor Frenzy in Off-Market Real Estate Looking at the real estate puzzle today, one might spot an unexpected surge in enthusiasm for off-market residential properties. We've got iFinder Offers, a real estate platform that's made it its business to connect the dots between homeowners and a gaggle of over 325 hungry investors. And according to their magic spreadsheets,...

California's Political Pot Stirs In the wild world of politics, California stands as a fiery beacon yet again. This time, CalExitNow, a fiery group championing California's self-determination, is taking aim at the state’s Republican Party. Reminds me of a stock under pressure—hesitate at your peril as the winds of change sweep through. Disqualification Petition: A...

A Shot in the Arm or a Sore Spot? INOVIO Pharmaceuticals is diving headfirst into the capital markets with a $75 million public offering, and let me tell you, the road ahead isn't paved with gold, yet. They've set out to raise funds by pricing 58,747,235 shares at $1.05 a pop, which might have you scratching your head if you're holding INO shares already. Breaking Down...

AiNET's Legal Triumph Shakes Up the IT Sector Well, talk about a courtroom drama. Greenberg Traurig just snagged a big win for AiNET over in Prince George's County, Maryland, and it's a classic reminder that due diligence isn't just a nice-to-have—it's a must. AiNET found itself in the center of a breach of contract brawl with Tech Finance Co., and guess what? The jury...

Revolutionizing Access: Pharmaceuticals Meet Telehealth In an era where digital disruption is shaking every sector, Eli Lilly (NYSE:LLY) isn't sitting idle. They've just forged a partnership with Hims & Hers (NYSE:HIMS), one that's diving headfirst into the telehealth revolution. We're talking a slick merger of pharmaceuticals and digital platforms—offering FDA-approved...

Everest Group's Legal Spiral: What's Happening? Folks, when a company feels like it's caught in an endless storm, investors better hold on tight. That's the situation Everest Group, Ltd. finds itself in, with an 11.4% stock dive that’s got investors reeling. Securities fraud allegations are rocking Everest like a hurricane, and The Law Offices of Frank R. Cruz have put...

Well, here we go again with another shake-up in the tech investment world. Brian Long, a name that's been whispered around more than a few boardroom tables, is dropping out of Atlantic Bridge to start his own gig across the pond in the United States. If you're tracking numbers, Atlantic Bridge is juggling a healthy €1.4bn in assets—no small potatoes. So, let's dig...

LaserAway's New Chapter in Paramus Out of the glitz of Los Angeles and into the hustle of Paramus, LaserAway's latest clinic isn't just a ribbon-cutting ceremony—it's a milestone in the aesthetic dermatology space. Boasting its 241st location, LaserAway is marking twenty years of relentless expansion without ever closing a single clinic. Now that's a track record that'd...

Adjusting Strategy Amid Financial Challenges The market's a tough beast, and TELUS seems to be wrestling with it, showing both grit and foresight in its latest quarterly update. Third quarter 2026 has TELUS down on revenues with a notable net loss but don't count them out yet. Their Transformation Strategy is a gamble worth watching. Where the Numbers Stand Here's the...

Alright, so here's the deal with Jersey Mike's Subs. These folks are storming into the stock market with an IPO that's about to get everyone talking. They're offering a meaty stack of shares—43,478,261 to be exact—hoping to lure investors into a world where sandwiches aren't just a food item, but an experience. Slide into that booth and get your wild predictions...

MicroStrategy's New Release Enhances AI Personalization MicroStrategy Incorporated (NASDAQ: MSTR), renowned for revolutionizing business intelligence through AI, has unveiled an innovative update to MicroStrategy ONE. This cutting-edge release is designed to help organizations quickly extract value from generative AI (GenAI), tailoring the AI experience to meet the...

Unlocking Business Potential with AI-Driven Solutions Orbit Local proudly introduces an innovative Marketing Automation and CRM platform powered by Artificial Intelligence. This robust solution is crafted to assist businesses in enhancing lead generation, improving customer engagement, and ultimately driving sales. With a seamless integration of automation features, AI...

HORNE Community Foundation Gives Back to Four Non-Profits $100,000 in total giving benefits organizations from across the United States. Recently, HORNE, a professional services firm, demonstrated its commitment to community support by announcing generous donations to four charities. These contributions, fulfilling specific missions, total $100,000 and aid organizations...

Significant Growth in the Solar Energy Market The solar energy market in Canada is experiencing remarkable evolution, with projections indicating an increase in size by approximately USD 2.25 billion during the period from 2025 to 2029. This growth is driven primarily by government initiatives and increasing acceptance of solar power as a viable and sustainable energy...